August 16, 2019
The biosimilar debut for Eli Lilly’s big-seller osteoporosis drug Forteo (teriparatide) is drawing near as the Japanese health ministry is scheduled to report late this month its plan to approve its first follow-on version filed by Mochida Pharmaceutical. If all...read more